- Disease: Post-COVID-19
- Study type: Randomised Clinical Trial, Treatment
- Study type descriptors: Interventional
- Objective: To evaluate the efficacy of VSL#3® compared to placebo in reducing fatigue in individuals with long COVID syndrome
- Number of participants enrolled: Enrollment data not available
- Study enrolling from to
- Study includes follow-up for 2 months
Study Data
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Probiotic
External Links
Other information
Funders/Sponsors:
- Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico
The information was provided with the aid of the study investigators
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to